Aaron Prodeus Selected Research

Aaron Prodeus Research Topics

7	Neoplasms (Cancer) 01/2022 - 08/2014
2	Arthritis (Polyarthritis) 01/2022 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2018
2	Inflammation (Inflammations) 09/2018 - 08/2014
1	Wilms Tumor (Wilm's Tumor) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Knee Osteoarthritis 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hepatitis 01/2017
1	Epilepsy (Aura) 01/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Huntington Disease (Huntington's Disease) 01/2017
1	Melanoma (Melanoma, Malignant) 04/2015
1	Hypersensitivity (Allergy) 08/2014
1	Infections 08/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2014
1	Multiple Sclerosis 08/2014

2	Nucleotide AptamersIBA 01/2022 - 04/2015
2	AntigensIBA 01/2022 - 01/2016
2	LigandsIBA 01/2016 - 08/2014
2	AntibodiesIBA 01/2016 - 04/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022
1	EpitopesIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	EnzymesIBA 01/2019
1	Carcinoembryonic AntigenIBA 10/2018
1	Fibronectins (Fibronectin)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018
1	LipidsIBA 01/2017
1	Concanavalin AIBA 01/2017
1	Poly I-CIBA 01/2016
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	Angiopoietin-1IBA 06/2015
1	VasculotideIBA 06/2015